HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jin-Soo Kim Selected Research

Adenine

1/2022Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice.
1/2018Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jin-Soo Kim Research Topics

Disease

42Neoplasms (Cancer)
04/2024 - 08/2004
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2023 - 06/2011
10Breast Neoplasms (Breast Cancer)
12/2020 - 06/2008
9Stomach Neoplasms (Stomach Cancer)
11/2019 - 02/2011
8Disease Progression
01/2023 - 02/2008
7Inborn Genetic Diseases (Disease, Hereditary)
01/2024 - 08/2015
7Prostatic Neoplasms (Prostate Cancer)
12/2023 - 01/2021
7Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2023 - 09/2017
6Squamous Cell Carcinoma of Head and Neck
07/2023 - 01/2015
5Lung Neoplasms (Lung Cancer)
11/2023 - 06/2011
5Adenocarcinoma
11/2023 - 05/2014
5Glaucoma
01/2023 - 01/2020
4Ganglion Cysts (Ganglion)
12/2020 - 01/2020
3Neoplasm Metastasis (Metastasis)
07/2023 - 01/2018
3Low Tension Glaucoma
01/2023 - 01/2020
3Neutropenia
01/2020 - 01/2019
3Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 07/2006
3Choroidal Neovascularization
05/2018 - 01/2017
3Hypoxia (Hypoxemia)
05/2018 - 08/2003
3Infections
01/2018 - 09/2008
3Carcinogenesis
11/2016 - 06/2011
3Hemophilia A (Haemophilia)
08/2015 - 03/2012
3Hemorrhage
06/2014 - 04/2008
2Adenocarcinoma of Lung
11/2023 - 09/2017
2Open-Angle Glaucoma (Glaucoma, Open Angle)
01/2023 - 11/2020
2Myopia
01/2023 - 01/2022
2Fatigue
02/2022 - 10/2020
2Brain Neoplasms (Brain Tumor)
01/2022 - 07/2021
2Exanthema (Rash)
01/2022 - 11/2019
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2022 - 01/2018
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2016
2Hypersensitivity (Allergy)
11/2021 - 01/2015
2Anaphylaxis (Anaphylactic Shock)
11/2021 - 01/2017
2Obesity
09/2021 - 01/2021
2Carcinoma (Carcinomatosis)
12/2020 - 06/2020
2Non-alcoholic Fatty Liver Disease
01/2020 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 03/2015
2Postoperative Pain
08/2018 - 09/2016
2Macular Degeneration (Age-Related Maculopathy)
01/2017 - 01/2017

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2008
10Retinaldehyde (Retinal)IBA
01/2023 - 01/2017
8MyokinesIBA
04/2024 - 01/2021
8Trastuzumab (Herceptin)FDA Link
09/2023 - 10/2009
8PlatinumIBA
07/2023 - 10/2013
7Cisplatin (Platino)FDA LinkGeneric
01/2021 - 12/2004
7Fluorouracil (Carac)FDA LinkGeneric
01/2019 - 02/2011
7taxaneIBA
12/2017 - 06/2008
6Tyrosine Kinase InhibitorsIBA
04/2024 - 10/2015
6ErbB Receptors (EGF Receptor)IBA
06/2023 - 10/2015
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 06/2008
5Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 10/2013
5Messenger RNA (mRNA)IBA
10/2020 - 04/2014
4Mitochondrial DNA (mtDNA)IBA
01/2024 - 01/2021
4CytokinesIBA
12/2023 - 01/2021
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 09/2008
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 01/2016
4Paclitaxel (Taxol)FDA LinkGeneric
11/2019 - 08/2004
3lazertinibIBA
06/2023 - 12/2019
3AntioxidantsIBA
09/2021 - 01/2017
3Immune Checkpoint InhibitorsIBA
08/2021 - 06/2020
3GemcitabineFDA Link
01/2021 - 06/2008
3Nonsense Codon (Nonsense Mutation)IBA
01/2021 - 01/2018
3Biomarkers (Surrogate Marker)IBA
07/2020 - 01/2015
3Small Interfering RNA (siRNA)IBA
06/2020 - 02/2014
3Indicators and Reagents (Reagents)IBA
01/2020 - 01/2015
3Factor VIII (Coagulation Factor VIII)IBA
08/2015 - 03/2012
3Insulin-Like PeptidesIBA
06/2015 - 06/2011
3Transcription Activator-Like Effector NucleasesIBA
01/2015 - 01/2014
33' Untranslated Regions (3' UTR)IBA
04/2014 - 02/2014
2Transcription Activator-Like EffectorsIBA
01/2024 - 06/2014
2Hormones (Hormone)IBA
12/2023 - 11/2013
2AfatinibIBA
11/2023 - 07/2021
2SynaptophysinIBA
11/2023 - 12/2007
2AndrogensIBA
10/2023 - 01/2022
2Remifentanil (Ultiva)FDA Link
11/2022 - 07/2012
2AdenineFDA LinkGeneric
01/2022 - 01/2018
2pembrolizumabIBA
08/2021 - 10/2019
2LigandsIBA
08/2021 - 01/2016
2AntibodiesIBA
08/2021 - 05/2020
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 12/2020
2Cysteine (L-Cysteine)FDA Link
01/2021 - 01/2016
2MicroRNAs (MicroRNA)IBA
01/2021 - 02/2014
2RNA (Ribonucleic Acid)IBA
10/2020 - 01/2017
2Etoposide (VP 16)FDA LinkGeneric
10/2019 - 01/2019
2Sevoflurane (Ultane)FDA LinkGeneric
01/2019 - 02/2016
2Opioid Analgesics (Opioids)IBA
08/2018 - 09/2017
2Analgesics (Analgesic Drugs)IBA
08/2018 - 09/2016
2AnthracyclinesIBA
12/2017 - 06/2008
2Pemetrexed (MTA)FDA Link
01/2017 - 10/2015

Therapy/Procedure

20Therapeutics
04/2024 - 10/2009
19Drug Therapy (Chemotherapy)
08/2021 - 12/2004
3Radiotherapy
11/2023 - 01/2021
3Cervical Plexus Block
01/2020 - 09/2016
3Transplantation
01/2019 - 07/2006
3Lasers (Laser)
05/2018 - 01/2017
3Combination Drug Therapy (Combination Chemotherapy)
04/2017 - 06/2008
2Immunotherapy
11/2023 - 07/2020
2Resistance Training
01/2022 - 01/2016
2Induction Chemotherapy
01/2022 - 01/2019
2Trabeculectomy (Trabeculoplasty)
01/2020 - 01/2019